Enalapril maleate and folic acid tablets for primary prevention of stroke in Chinese hypertensive patients: a post-marketing double-blind randomized controlled trial
机构:[1]Beijing Univ, Hosp 1, Beijing 100871, Peoples R China;[2]Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China;[3]301 Hosp, Beijing, Peoples R China;[4]Beijing Univ, People s Hosp, Beijing 100871, Peoples R China;[5]Beijing Tiantan Hosp, Beijing, Peoples R China;首都医科大学附属天坛医院[6]Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China;[7]Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China;广东省中医院[8]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China;[9]Lianyungang Municipal First Peoples Hosp, Lianyungang, Peoples R China;[10]Shenzhen Univ, Inst Biomed, Shenzhen, Peoples R China;[11]Lianyungang Modern Cardiovasc Dis Prevent & Treat, Lianyungang, Peoples R China;[12]Anhui Med Univ, Inst Biomed, Hefei, Peoples R China;[13]Childrens Mem Hosp, Chicago, IL 60614 USA;[14]Univ Illinois, Chicago, IL USA
第一作者机构:[1]Beijing Univ, Hosp 1, Beijing 100871, Peoples R China;
推荐引用方式(GB/T 7714):
Huo Yong,Liu Lishen,Li Xiaoying,et al.Enalapril maleate and folic acid tablets for primary prevention of stroke in Chinese hypertensive patients: a post-marketing double-blind randomized controlled trial[J].INTERNATIONAL JOURNAL OF CARDIOLOGY.2009,137:S39-S39.doi:10.1016/j.ijcard.2009.09.128.
APA:
Huo, Yong,Liu, Lishen,Li, Xiaoying,Sun, Ningling,Huang, Yining...&Xu, Xiping.(2009).Enalapril maleate and folic acid tablets for primary prevention of stroke in Chinese hypertensive patients: a post-marketing double-blind randomized controlled trial.INTERNATIONAL JOURNAL OF CARDIOLOGY,137,
MLA:
Huo, Yong,et al."Enalapril maleate and folic acid tablets for primary prevention of stroke in Chinese hypertensive patients: a post-marketing double-blind randomized controlled trial".INTERNATIONAL JOURNAL OF CARDIOLOGY 137.(2009):S39-S39